Target Price Playground

RNA
$6.51
IV 35.0% Target $8.68 (+33.2%)

LEAP Setup

1-Click Institutional Target Anchors:
6m
9m
12m
18m
24m

Quick Stats

Current Price
$6.51
Target Move
+33.2%
Horizon
12 months
ATM Breakeven
$6.93
Profit Path — If RNA Trends to $9
Assumes linear price movement from $7 to $9 over 12 months
Deep ITM (Stock Repl.) ($5) ATM ($5) 10% OTM ($5) 20% OTM ($10) Break-even
Scenario Matrix — ATM $5 Call
Price % Today Feb 15 May 16 Aug 14 Nov 12 (exp)
$5 -20% -$101 -$112 -$126 -$143 -$172
$6 -15% -$78 -$89 -$103 -$119 -$139
$6 -10.1% -$54 -$65 -$78 -$93 -$107
$6 -5% -$27 -$39 -$51 -$64 -$74
$6 -2.1% -$11 -$22 -$34 -$46 -$55
$7 -0.1% -$0 -$11 -$23 -$34 -$42
$7 +2.1% +$12 +$1 -$10 -$21 -$28
$7 +5% +$28 +$18 +$8 -$2 -$9
$7 +10.1% +$58 +$48 +$39 +$30 +$24
$7 +15% +$87 +$78 +$69 +$62 +$56
$8 +20% +$118 +$110 +$102 +$95 +$89
$9 TARGET +33.2% +$201 +$193 +$187 +$181 +$175
Insights
Reasonable IV
IV at 35% is in the normal range (25-45%). Premiums are fairly priced.
2.7x Leverage
The Deep ITM (Stock Repl.) $5 call provides 2.7x capital leverage vs owning 100 shares outright at a +33.2% target move.
Breakeven: $7 (+6%)
RNA needs to reach $7 (+6% from here) by expiry just to break even on the ATM call. Your target of $9 is above this level.
Theta: $0/day ($4/mo)
This contract expires in 360 days (~12 months). Initial time decay costs ~$4/month (~$11 or 5.7% of entry cost over the next 90 days) and accelerates non-linearly inside the final 60–90 DTE.

LEAP Options

Deep ITM (Stock Repl.) BEST PICK EST
$5 Call
Exp: Nov 12, 2027 (360d)
Entry / Contract
$193
Profit at Target
$173
ROI
89.9%
Leverage vs Stock
2.7x
Breakeven Price
$6.93
Extrinsic Value
$0.41 (21.5%)
PMCC Monthly Income (~30d $7 Call): ~$7/mo (41.4% ann. yield on LEAP)
Δ 0.856
Θ $-0.12/d
Vega 0.01
ATM EST
$5 Call
Exp: Nov 12, 2027 (360d)
Entry / Contract
$193
Profit at Target
$173
ROI
89.9%
Leverage vs Stock
2.7x
Breakeven Price
$6.93
Extrinsic Value
$0.41 (21.5%)
PMCC Monthly Income (~30d $7 Call): ~$7/mo (41.4% ann. yield on LEAP)
Δ 0.856
Θ $-0.12/d
Vega 0.01
10% OTM EST
$5 Call
Exp: Nov 12, 2027 (360d)
Entry / Contract
$193
Profit at Target
$173
ROI
89.9%
Leverage vs Stock
2.7x
Breakeven Price
$6.93
Extrinsic Value
$0.41 (21.5%)
PMCC Monthly Income (~30d $7 Call): ~$7/mo (41.4% ann. yield on LEAP)
Δ 0.856
Θ $-0.12/d
Vega 0.01
20% OTM EST
$10 Call
Exp: Nov 12, 2027 (360d)
Entry / Contract
$18
Profit at Target
$-18
ROI
-100.0%
Leverage vs Stock
-3.0x
Breakeven Price
$10.18
Extrinsic Value
$0.18 (100.0%)
Out-of-the-money leverage play (PMCC requires Deep ITM ≥0.70Δ)
Δ 0.176
Θ $-0.09/d
Vega 0.02